Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if it is feasible and safe to use the REG1
Anticoagulation System instead of unfractionated heparin during percutaneous coronary
intervention (PCI) in subjects with coronary artery disease (CAD).